CHGCY
Price:
$23.66
Market Cap:
$12.45T
Chugai Pharmaceutical Co., Ltd., along with its affiliated entities, is a global pharmaceutical company deeply involved in the discovery, development, production, marketing, and distribution of medicines. Its diverse product portfolio addresses a range of therapeutic areas. Key cancer treatments include Avastin, Tecentriq, Perjeta, Alecensa, Herceptin, Kadcyla, Rituxan, Gazyva, and Xeloda. For osteoporosis, it offers Actemra, Edirol, and Bonviva. Renal conditions are treated with products such as Mircera and Oxarol. Furthermore, its lineup for neurological and other diverse ailments features Hemlibra, CellCept, and Enspryng. The company maintains an active pipeline of investigational therapi...[Read more]
Industry
Drug Manufacturers - General
IPO Date
2012-08-03
Stock Exchange
OTC
Ticker
CHGCY
According to Chugai Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 28.85. This represents a change of 2.28% compared to the average of 28.21 of the last 4 quarters.
The mean historical PE Ratio of Chugai Pharmaceutical Co., Ltd. over the last ten years is 31.55. The current 28.85 PE Ratio has changed 9.04% with respect to the historical average. Over the past ten years (40 quarters), CHGCY's PE Ratio was at its highest in in the December 2017 quarter at 50.82. The PE Ratio was at its lowest in in the March 2022 quarter at 12.78.
Average
31.55
Median
32.72
Minimum
14.80
Maximum
43.37
Discovering the peaks and valleys of Chugai Pharmaceutical Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 82.51%
Maximum Annual PE Ratio = 43.37
Minimum Annual Increase = -51.88%
Minimum Annual PE Ratio = 14.80
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | 31.26 | 5.10% |
| 2024 | 29.74 | 10.13% |
| 2023 | 27.00 | 82.51% |
| 2022 | 14.80 | -27.00% |
| 2021 | 20.27 | -51.88% |
| 2020 | 42.12 | 20.27% |
| 2019 | 35.02 | -7.26% |
| 2018 | 37.76 | -12.94% |
| 2017 | 43.37 | 26.84% |
| 2016 | 34.19 | -9.68% |
The current PE Ratio of Chugai Pharmaceutical Co., Ltd. (CHGCY) is less than than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
29.33
5-year avg
24.61
10-year avg
31.55
Chugai Pharmaceutical Co., Ltd.’s PE Ratio is greater than GSK plc (13.61), greater than Daiichi Sankyo Company, Limited (18.76), greater than Daiichi Sankyo Company, Limited (18.76), less than Sartorius AG (96.85), greater than Siemens Healthineers AG (18.59), greater than Merck KGaA (22.90), greater than Merck KGaA (22.90), greater than CSL Limited (25.23), less than Ipsen S.A. (29.47), less than HOYA Corporation (37.14),
| Company | PE Ratio | Market cap |
|---|---|---|
| 13.61 | $105.17B | |
| 18.76 | $29.40B | |
| 18.76 | $29.55B | |
| 96.85 | $75.80B | |
| 18.59 | $44.15B | |
| 22.90 | $66.22B | |
| 22.90 | $66.57B | |
| 25.23 | $34.66B | |
| 29.47 | $57.98B | |
| 37.14 | $57.34B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Chugai Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Chugai Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Chugai Pharmaceutical Co., Ltd.'s PE Ratio?
How is the PE Ratio calculated for Chugai Pharmaceutical Co., Ltd. (CHGCY)?
What is the highest PE Ratio for Chugai Pharmaceutical Co., Ltd. (CHGCY)?
What is the 3-year average PE Ratio for Chugai Pharmaceutical Co., Ltd. (CHGCY)?
What is the 5-year average PE Ratio for Chugai Pharmaceutical Co., Ltd. (CHGCY)?
How does the current PE Ratio for Chugai Pharmaceutical Co., Ltd. (CHGCY) compare to its historical average?